Silymarin ameliorates post-weaning bisphenol A exposure-induced cardiotoxicity via suppression of TLR4/VCAM signaling in male Wistar rats

View at publisher
Authors: Waid Adeoye Saka, Victory Jesutoyosi Ashonibare, Rahmon Ayomide Aderoju, Abisola Toluwanimi Lawal, Paulina Oyindamola Kajola, Cecilia Adedeji Adegbola, Tunmise Maryanne Akhigbe, Babatunde David Ogunkola, Adebola Olayemi Akintola, Roland Eghoghosoa Akhigbe
Cited by: 1
References: 56

Abstract

This study assessed the cardiotoxic effect of post-weaning BPA exposure and the potential ameliorative effect of silymarin on BPA-induced cardiotoxicity. Twenty-four male Wistar rats were randomized into four groups: the control, silymarin-treated, bisphenol A (BPA)-treated, and the BPA+silymarin-treated. Post-weaning BPA exposure led to a rise in cardiac injury markers, malondialdehyde, and iron contents, and a reduction in GSH and GPX4. Moreover, BPA elevated cardiac TNF-α, IL-1β, MPO, VCAM-1, NF-kB, TLR4, caspase 3, cytochrome c, and DFI. Additionally, BPA promoted amyloid accumulation and distorted cardiac histoarchitecture. Nonetheless, silymarin treatment attenuated BPA-induced biochemical and histological alterations. In conclusion, silymarin attenuated BPA-induced cardiotoxicity, potentially via modulation of TLR4/VCAM signaling. Further studies are needed to confirm these mechanisms.

Fields of Study & Subjects

Silymarin and Mushroom Poisoning Chemotherapy-induced cardiotoxicity and mitigation Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Drug and Chemical Toxicology
Publisher
Informa UK Limited
Volume
49
Issue
3
Pages
489–502
Publication date
26 January 2026
Language
EN